By Jennifer Chiou and Cristal Cody
New York, May 12 - Pfizer Inc. brought the following five-tranche issue to market on Monday:
• $1 billion aggregate principal amount of 1.1% notes due 2017;
• $500 million aggregate principal amount of floating-rate notes due 2017;
• $1.5 billion aggregate principal amount of 2.1% notes due 2019;
• $1 billion aggregate principal amount of 3.4% notes due 2024; and
• $500 million aggregate principal amount of 4.4% notes due 2044.
The company had initially planned a four-tranche offering of notes, according to a preliminary prospect supplement filed with the Securities and Exchange Commission on Monday.
BofA Merrill Lynch, Barclays, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC are the underwriters.
Proceeds will be used for general corporate purposes, including pre-funding the repayment at maturity of its 4.75% notes due December 2014 and a portion of its 5.35% notes due March 2015.
Settlement is anticipated for May 15.
Pfizer is a New York City-based biopharmaceutical company.
| Issuer: | Pfizer Inc.
|
| Issue: | Fixed and floating-rate notes
|
| Total amount: | $4.5 billion
|
| Bookrunners: | BofA Merrill Lynch, Barclays, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC
|
| Trade date: | May 12
|
| Settlement date: | May 15
|
|
|
| Three-year fixed-rate notes
|
| Amount: | $1 billion
|
| Maturity: | 2017
|
| Coupon: | 1.1%
|
|
|
| Three-year floating-rate notes
|
| Amount: | $500 million
|
| Maturity: | 2017
|
|
|
| Five-year notes
|
| Amount: | $1.5 billion
|
| Maturity: | 2019
|
| Coupon: | 2.1%
|
|
|
| 10-year notes
|
| Amount: | $1 billion
|
| Maturity: | 2024
|
| Coupon: | 3.4%
|
|
|
| 30-year bonds
|
| Amount: | $500 million
|
| Maturity: | 2044
|
| Coupon: | 4.4%
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
